Pages that link to "Q48387159"
Jump to navigation
Jump to search
The following pages link to Crude caffeine reduces memory impairment and amyloid β(1-42) levels in an Alzheimer's mouse model (Q48387159):
Displaying 31 items.
- Structure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the Drawbacks (Q26740559) (← links)
- Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases (Q26859141) (← links)
- Caffeine: cognitive and physical performance enhancer or psychoactive drug? (Q28080581) (← links)
- The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy (Q30668465) (← links)
- Antroquinonol Lowers Brain Amyloid-β Levels and Improves Spatial Learning and Memory in a Transgenic Mouse Model of Alzheimer's Disease (Q30668645) (← links)
- Bioactive micronutrients in coffee: recent analytical approaches for characterization and quantification. (Q33710362) (← links)
- The Safety of Ingested Caffeine: A Comprehensive Review (Q33729422) (← links)
- Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review. (Q33971113) (← links)
- Gas chromatography time-of-flight mass spectrometry (GC-TOF-MS)-based metabolomics for comparison of caffeinated and decaffeinated coffee and its implications for Alzheimer's disease (Q34011240) (← links)
- Role of microglia adenosine A(2A) receptors in retinal and brain neurodegenerative diseases (Q34014053) (← links)
- Caffeine inhibits acetylcholinesterase, but not butyrylcholinesterase (Q36913687) (← links)
- Therapeutic potential of culinary-medicinal mushrooms for the management of neurodegenerative diseases: diversity, metabolite, and mechanism (Q38198104) (← links)
- Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer's disease (Q38199970) (← links)
- History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents (Q38395423) (← links)
- Health benefits of methylxanthines in neurodegenerative diseases (Q38772021) (← links)
- Caffeine impact on working memory-related network activation patterns in early stages of cognitive decline (Q38910116) (← links)
- The neuroprotective effects of caffeine in neurodegenerative diseases (Q39186884) (← links)
- Relationships Between Caffeine Intake and Risk for Probable Dementia or Global Cognitive Impairment: The Women's Health Initiative Memory Study (Q40563346) (← links)
- Protective effect of chronic caffeine intake on gene expression of brain derived neurotrophic factor signaling and the immunoreactivity of glial fibrillary acidic protein and Ki-67 in Alzheimer's disease (Q42230705) (← links)
- Bioappearance and pharmacokinetics of bioactives upon coffee consumption. (Q43412099) (← links)
- Identification and evaluation of antioxidants in Japanese parsley (Q46564111) (← links)
- Isoflurane anesthesia in aged mice and effects of A1 adenosine receptors on cognitive impairment. (Q47711913) (← links)
- Impact of Coffee and Cacao Purine Metabolites on Neuroplasticity and Neurodegenerative Disease (Q50125651) (← links)
- Long-term Treatment with Low-Dose Caffeine Worsens BPSD-Like Profile in 3xTg-AD Mice Model of Alzheimer's Disease and Affects Mice with Normal Aging (Q50421252) (← links)
- Neuroprotective Effects and Mechanisms of Tea Bioactive Components in Neurodegenerative Diseases. (Q52370795) (← links)
- Impact of Coffee, Wine, and Chocolate Consumption on Cognitive Outcome and MRI Parameters in Old Age (Q57060725) (← links)
- Phenylindanes in Brewed Coffee Inhibit Amyloid-Beta and Tau Aggregation (Q58122620) (← links)
- Neuroprotective Effects of Spinosin on Recovery of Learning and Memory in a Mouse Model of Alzheimer's Disease (Q89168518) (← links)
- 5-Caffeoylquinic Acid Ameliorates Cognitive Decline and Reduces Aβ Deposition by Modulating Aβ Clearance Pathways in APP/PS2 Transgenic Mice (Q89782800) (← links)
- Green tea and coffee intake and risk of cognitive decline in older adults: the National Institute for Longevity Sciences, Longitudinal Study of Aging (Q90211330) (← links)
- Novel Players in the Aging Synapse: Impact on Cognition (Q90321608) (← links)